Sign in

CIK 0001752828 · <br>Emerging growth company

Celularity Inc

Sign in to watch
Ticker
CELU
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831702591
Phone
(908) 768-2170
Business address
170 PARK AVE, FLORHAM PARK, NJ, 07932
Former names
GX Acquisition Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2025-02-17 Beers David C Chief Financial Officer Option exercise +12,500 21,932
2025-02-17 Beers David C Chief Financial Officer Shares withheld for taxes −4,396 $2.14 $9K 17,536
2025-02-17 Beers David C Chief Financial Officer Option exercise · Restricted Stock Units −12,500
2025-02-17 Haines John R Senior Exec Vice President Option exercise +20,000 35,092
2025-02-17 Haines John R Senior Exec Vice President Shares withheld for taxes −7,035 $2.14 $15K 28,057
2025-02-17 Haines John R Senior Exec Vice President Option exercise · Restricted Stock Units −20,000 0
2025-01-24 Lim Kok Thay 10% owner Option exercise +535,274 $2.07 $1.1M 5,682,649
2025-01-24 Lim Kok Thay 10% owner Option exercise +652,981 $2.07 $1.4M 6,335,630
2025-01-24 Lim Kok Thay 10% owner Other disposition · Warrants (Right to Buy) −535,274 0
2025-01-24 Lim Kok Thay 10% owner Other acquisition · Warrants (Right to Buy) +535,274 535,274
2025-01-24 Lim Kok Thay 10% owner Other disposition · Warrants (Right to Buy) −652,981 0
2025-01-24 Lim Kok Thay 10% owner Other acquisition · Warrants (Right to Buy) +652,981 652,981
2025-01-24 Lim Kok Thay 10% owner Option exercise · Warrants (Right to Buy) −535,274 0
2025-01-24 Lim Kok Thay 10% owner Option exercise · Warrants (Right to Buy) −652,981 0
2024-12-19 Diamandis Peter Director Grant or award +67,416 201,723
2024-12-19 Diamandis Peter Director Grant or award · Stock Option (Right to Buy) +84,746 416,459
2024-12-19 Parks Diane L. Director Grant or award +67,416 303,482
2024-12-19 Parks Diane L. Director Grant or award · Stock Option (Right to Buy) +84,746 362,524
2024-12-19 Ling Geoffrey M.D. Director Grant or award +67,416 67,416
2024-12-19 Ling Geoffrey M.D. Director Grant or award · Stock Option (Right to Buy) +84,746 1,334,746

Page 5 of 15 · 299 trades